Rhythm and Blues: Atrial Fibrillation, Depression, and the Autonomic Nervous System

Area of Science:

• Cardiology
• Psychiatry
• Autonomic Neuroscience

Background:

• Atrial fibrillation (AF) frequently co-occurs with depression.
• Autonomic dysfunction is implicated in both AF and depression, suggesting a shared pathophysiology.
• Understanding this link is crucial for integrated treatment strategies.

Purpose of the Study:

• To review the literature on the interplay between depression, AF, and autonomic dysfunction.
• To explore the potential of targeting autonomic dysfunction for managing comorbid AF and depression.
• To evaluate the role of antidepressant medications and behavioral therapies.

Main Methods:

• A narrative review of existing studies was performed.
• Literature search focused on heart rate variability (HRV) as a measure of autonomic function.
• Included studies examined catheter ablation, selective serotonin reuptake inhibitors (SSRIs), and behavioral interventions.

Main Results:

• Catheter ablation for AF showed short-term improvements in quality of life and anxiety, linked to autonomic changes.
• SSRIs may mitigate excessive HRV changes and autonomic dysfunction in AF patients.
• Behavioral depression treatments reduced symptom perception and healthcare use in AF patients.

Conclusions:

• Effective depression treatment can directly benefit AF management through autonomic modulation.
• Indirect benefits include improved lifestyle adherence and reduced symptom burden.
• Further research is needed on SSRI safety with antiarrhythmic drugs, considering QT interval effects.